University of Glasgow
Understanding the link between mutations in the enzyme PDE10A and hyperkinetic movement disorders
Abstract
dc:description.abstractThe regulation of cyclic nucleotide levels, particularly by Phosphodiesterase 10A (PDE10A), is critical for neurological function, and its dysregulation is implicated in hyperkinetic chorea-like disorders such as Huntington’s Disease (HD). While PDE10A inhibition has been explored as a therapeutic strategy, clinical trials have yielded limited success, suggesting a more complex pathology than previously understood. Recent studies on PDE10A mutants propose that a loss of PDE10A function, rather than compensatory downregulation, may contribute to these symptoms. This investigation uses biochemical techniques to characterize five newly identified human PDE10A mutants (A530T, Asn838AlafsTer46, E890D, R182Ter, and D1023_N1024insY), four of which are pathogenic and one (E890D) is non-pathogenic. Using immunoblotting, RT-qPCR, and confocal microscopy in HEK293T cells, I assessed protein expression, mRNA levels, subcellular localization, and PDE enzyme activity. Our findings reveal that the pathogenicity of early termination mutants, R182Ter and Asn838AlafsTer46, is not fully clear, and caused either by a lack of key functional domains or due to NMD degrading the mRNA of these mutants. In contrast, other pathogenic mutants (A530T and D1023_N1024insY) exhibited normal expression and localization, but showed a profound loss of phosphodiesterase activity.
Degree
thesis:*- Level dc:type.qualificationlevel
- MSc(R)
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Arroyo Gutierrez, Hugo
Subjects
dc:subject × 2Rights
- Language dc:language
- en
Identifiers
dc:identifier.*- DOI dc:identifier.doi
- https://doi.org/10.5525/gla.thesis.85433